Palliative treatment of germ cell cancer.

BORIS DOI
Publisher DOI
PubMed ID
30415106
Description
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.
Date of Publication
2018-12
Publication Type
article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
Drug therapy Germ cell cancer Germ cell tumor Palliative treatment Platinum-refractory
Language(s)
en
Contributor(s)
Oing, Christoph
Giannatempo, Patrizia
Honecker, Friedemann
Oechsle, Karin
Bokemeyer, Carsten
Additional Credits
Universitätsklinik für Medizinische Onkologie
Series
Cancer treatment reviews
Publisher
Elsevier
ISSN
1532-1967
Access(Rights)
open.access
Show full item